Northern Trust’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.54M | Buy |
|
|||||
|
2025
Q1 | $6.13M | Buy |
|
|||||
|
2024
Q4 | $8.12M | Buy |
|
|||||
|
2024
Q3 | $9.24M | Buy |
|
|||||
|
2024
Q2 | $2.01M | Buy |
|
|||||
|
2024
Q1 | $2.52M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $44.1K | Hold |
|
|||||
|
2023
Q1 | $28.4K | Buy |
|
|||||
|
2022
Q4 | $38.9K | Buy |
|
|||||
|
2022
Q3 | $36K | Hold |
|
|||||
|
2022
Q2 | $35K | Sell |
|
|||||
|
2022
Q1 | $768K | Sell |
|
|||||
|
2021
Q4 | $1.66M | Sell |
|
|||||
|
2021
Q3 | $2.91M | Sell |
|
|||||
|
2021
Q2 | $2.56M | Sell |
|
|||||
|
2021
Q1 | $3.57M | Sell |
|
|||||
|
2020
Q4 | $3.78M | Buy |
|
|||||
|
2020
Q3 | $3.35M | Sell |
|
|||||
|
2020
Q2 | $4.62M | Buy |
|
|||||
|
2020
Q1 | $1.38M | Buy |
|
|||||
|
2019
Q4 | $2.24M | Sell |
|
|||||
|
2019
Q3 | $2.32M | Buy |
|
|||||
|
2019
Q2 | $1.61M | Buy |
|
|||||
|
2019
Q1 | $1.74M | Buy |
|
|||||
|
2018
Q4 | $1.37M | Buy |
|
|||||
|
2018
Q3 | $1.74M | Buy |
|
|||||
|
2018
Q2 | $1.87M | Buy |
|
|||||
|
2018
Q1 | $181K | Buy |
|
|||||
|
2017
Q4 | $89K | Hold |
|
|||||
|
2017
Q3 | $81K | Hold |
|
|||||
|
2017
Q2 | $64K | Hold |
|
|||||
|
2017
Q1 | $123K | Buy |
|